Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug 2;12(8):1972-1981.
doi: 10.1080/21645515.2016.1171948. Epub 2016 Jul 6.

Pertussis vaccination in pregnancy

C Mary Healy  1
Affiliations
Review

Pertussis vaccination in pregnancy

C Mary Healy. Hum Vaccin Immunother. .

Abstract

Pertussis has had a resurgence with the highest incidence and complication rates in young infants, and deaths occurring mainly at < age 3 months. Infants are infected by older individuals whose immunity has waned. Strategies such as targeted immunization of infant caregivers have had limited success. Pertussis vaccination in pregnancy may protect infants through passive and active transfer of maternal antibodies that protect the infant until the primary immunization series. Studies show vaccinating pregnant women with acellular pertussis vaccine is safe for mother and infant, immunogenic with efficient transfer of antibodies to infants, and effective in preventing pertussis in young infants. Vaccine uptake in pregnant women is sub-optimal, but provider recommendation is the most important factor in improving vaccination rates. Studies are ongoing to determine the best timing of vaccination to protect infants, and into other strategies. Vaccinating pregnant women offers hope to prevent pertussis-related morbidity and mortality in infants worldwide.

Keywords: disease burden; maternal immunization; pertussis; safety and immunogenicity.

PubMed Disclaimer

References

    1. World Health Organization WHO-recommended surveillance standard of pertussis. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surve.... Accessed January31, 2016.
    1. Cherry JD. Epidemic pertussis in 2012–the resurgence of a vaccine-preventable disease. N Engl J Med 2012; 367:785-7; PMID:22894554; http://dx.doi.org/10.1056/NEJMp1209051 - DOI - PubMed
    1. Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013; 13:151; PMID:23530907; http://dx.doi.org/10.1186/1471-2334-13-151 - DOI - PMC - PubMed
    1. Guiso N, Wirsing von Konig CH, Forsyth K, Tan T, Plotkin SA. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11–12 January 2010. Vaccine 2011; 29:1115-21; PMID:21168525; http://dx.doi.org/10.1016/j.vaccine.2010.12.010 - DOI - PubMed
    1. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007; 7:614-24; PMID:17537674; http://dx.doi.org/10.1016/S1473-3099(07)70113-5 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources